Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1980 Apr;4:209–216.

Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity.

G W Barendsen
PMCID: PMC2149188  PMID: 7000122

Abstract

A review is presented of the advantages and problems associated with the use of in vitro assays of cellular clonogenic capacity when used to analyse responses of tumours treated in vivo, either with radiation or chemotherapeutic agents. Three questions are considered: (1) Does the cell suspension obtained by the dispersion technique from various types of solid tumours provide an adequately random sample of the cells initially present in the tumour? (2) Are the properties of cells in suspensions obtained from solid tumours assayed in optimal conditions in vitro? (3) Are the properties expressed and analysed by in vitro techniques equivalent to the properties that the same cells would have expressed if they had been left in vivo, either in untreated or in treated tumours? It is concluded that the in vitro assay provides a valuable tool to analyse tumour responses but that the data obtained must be complemented by information on cell kinetics and other factors to obtain a complete description of tumour responses and to correlate them with tumour curability and growth delay.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barendsen G. W., Broerse J. J. Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV x-rays. I. Effects of single exposures. Eur J Cancer. 1969 Sep;5(4):373–391. doi: 10.1016/0014-2964(69)90051-6. [DOI] [PubMed] [Google Scholar]
  2. Barendsen G. W., Broerse J. J. Experimental radiotherapy of a rat rhabdomyosarcoma with 15 meV neutrons and 300 kV x-rays. II. Effects of ractionated treatments, applied five times a week for several weeks. Eur J Cancer. 1970 Apr;6(2):89–109. doi: 10.1016/0014-2964(70)90006-x. [DOI] [PubMed] [Google Scholar]
  3. Barendsen G. W., Roelse H., Hermens A. F., Madhuizen H. T., van Peperzeel H. A., Rutgers D. H. Clonogenic capacity of proliferating and nonproliferating cells of a transplantable rat rhabdomyosarcoma in relation to its radiosensitivity. J Natl Cancer Inst. 1973 Nov;51(5):1521–1526. doi: 10.1093/jnci/51.5.1521. [DOI] [PubMed] [Google Scholar]
  4. Begg A. C., Fu K. K., Kane L. J., Phillips T. L. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res. 1980 Jan;40(1):145–154. [PubMed] [Google Scholar]
  5. Courtenay V. D., Smith I. E., Peckham M. J., Steel G. G. In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature. 1976 Oct 28;263(5580):771–772. doi: 10.1038/263771a0. [DOI] [PubMed] [Google Scholar]
  6. Courtenay V. D., Smith I. E., Steel G. G. The effect of misonidazole on the radiation response of clonogenic human pancreatic carcinoma cells. Br J Cancer Suppl. 1978 Jun;3:225–227. [PMC free article] [PubMed] [Google Scholar]
  7. Dawson K. B., Madoc-Jones H., Mauro F., Peacock J. H. Studies on the radiobiology of a rat sarcoma treated in situ and assayed in vitro. Eur J Cancer. 1973 Jan;9(1):59–68. doi: 10.1016/0014-2964(73)90044-3. [DOI] [PubMed] [Google Scholar]
  8. HEWITT H. B., WILSON C. W. A survival curve for mammalian leukaemia cells irradiated in vivo (implications for the treatment of mouse leukaemia by whole-body irradiation). Br J Cancer. 1959 Mar;13(1):69–75. doi: 10.1038/bjc.1959.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hahn G. M., Ray G. R., Gordon L. F., Kallman R. F. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. J Natl Cancer Inst. 1973 Feb;50(2):529–533. doi: 10.1093/jnci/50.2.529. [DOI] [PubMed] [Google Scholar]
  10. Hermens A. F., Barendsen G. W. The proliferative status and clonogenic capacity of tumour cells in a transplantable rhabdomyosarcoma of the rat before and after irradiation with 800 rad of X-rays. Cell Tissue Kinet. 1978 Jan;11(1):83–100. doi: 10.1111/j.1365-2184.1978.tb00877.x. [DOI] [PubMed] [Google Scholar]
  11. Hill R. P. An appraisal of in vivo assays of excised tumours. Br J Cancer Suppl. 1980 Apr;4:230–239. [PMC free article] [PubMed] [Google Scholar]
  12. Kal H. B., Barendsen G. W. Cell survival and growth delay in rat R-1 tumours after radiation and vinblastine treatment. Br J Cancer Suppl. 1980 Apr;4:275–278. [PMC free article] [PubMed] [Google Scholar]
  13. Kal H. B. Distributions of cell volume and DNA content of rhabdomyosarcoma cells growing in vitro and in vivo after irradiation. Eur J Cancer. 1973 Jan;9(1):77–79. doi: 10.1016/0014-2964(73)90046-7. [DOI] [PubMed] [Google Scholar]
  14. Kal H. B. Proliferation behaviour of P and Q cells in a rat rhabdomyosarcoma after irradiation as determined by DNA measurements. Eur J Cancer. 1973 Oct;9(10):753–756. doi: 10.1016/0014-2964(73)90067-4. [DOI] [PubMed] [Google Scholar]
  15. McNally N. J. A comparison of the effects of radiation on tumour growth delay and cell survival. The effect of oxygen. Br J Radiol. 1973 Jun;46(546):450–455. doi: 10.1259/0007-1285-46-546-450. [DOI] [PubMed] [Google Scholar]
  16. McNally N. J. A low oxygen-enhancement ratio for tumour-cell survival as compared with that for tumour-growth delay. Int J Radiat Biol Relat Stud Phys Chem Med. 1972 Oct;22(4):407–410. doi: 10.1080/09553007214551281. [DOI] [PubMed] [Google Scholar]
  17. Rasey J. S., Carpenter R. E., Nelson N. J. Response of EMT-6 tumors to single fractions of X rays and cyclotron neutrons. Evaluation and comparison of multiple endpoints. Radiat Res. 1977 Aug;71(2):430–446. [PubMed] [Google Scholar]
  18. Rasey J. S., Nelson N. J. Response of an in vivo-in vitro tumour to X-rays and cytotoxic drugs: effect of tumour disaggregation method on cell survival. Br J Cancer Suppl. 1980 Apr;4:217–221. [PMC free article] [PubMed] [Google Scholar]
  19. Reinhold H. S. A cell dispersion technique for use in quantitative transplantation studies with solid tumours. Eur J Cancer. 1965 Jun;1(1):67–71. doi: 10.1016/0014-2964(65)90081-2. [DOI] [PubMed] [Google Scholar]
  20. Rockwell S. In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy. Lab Anim Sci. 1977 Oct;27(5 Pt 2):831–851. [PubMed] [Google Scholar]
  21. Steel G. G., Adams K. Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res. 1975 Jun;35(6):1530–1535. [PubMed] [Google Scholar]
  22. Steel G. G., Adams K., Stephens T. C. Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Br J Cancer. 1977 Nov;36(5):618–624. doi: 10.1038/bjc.1977.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stephens T. C., Peacock J. H. Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer. 1978 Nov;38(5):591–598. doi: 10.1038/bjc.1978.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Twentyman P. R. An artefact in clonogenic assays of bleomycin cytotoxicity. Br J Cancer. 1977 Nov;36(5):642–644. doi: 10.1038/bjc.1977.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Twentyman P. R. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay. Cancer Res. 1978 Aug;38(8):2395–2400. [PubMed] [Google Scholar]
  26. Twentyman P. R. Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1213–1220. doi: 10.1016/0360-3016(79)90641-2. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES